SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

NMDC, 3i Infotech and KDDL to see some action today

Aurobindo Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524804 | NSE: AUROPHARMA

21 Nov 2022 Evaluate

NMDC will be spending nearly Rs 900 crore in the next two to three years to ramp up iron ore production from seven million tonnes per annum (MTPA) to 10 million tonnes, from its Kumaraswamy mines in Karnataka. An Expert Appraisal Committee under the Minister of Environment and Forests has given its green signal for Environmental Clearance in a meeting held during November 9-11 allowing NMDC to increase the production and the EC is valid up to 2042.

3i Infotech has received a multi-year contract from Indian state refiner Hindustan Petroleum Corporation (HPCL). The order value is pegged at approximately Rs 51 crore (including taxes) over the tenure of 3 years. HPCL has been a longstanding customer of 3i Infotech, with the company serving them primarily in North India. However, under the new contract, the remit would include 3i Infotech taking its service across the country including all HPCL locations and datacenters. Overall, they will manage and support the IT Infrastructure of HPCL, to include offices, refinery, and retail units in over 70 circles across Pan-India. 3i Infotech will look to strengthen their presence in India and in the Oil and Natural Energy sector.

KDDL’s wholly owned subsidiary -- Kamla International Holdings SA (KIH) has acquired 3,000 equity shares (15%) of Pylania, SA from its existing shareholder, which resulted in increase of KIH equity shareholding from 47.5% to 62.5%. Therefore, Pylania SA has become 100% subsidiary of the Company.

Advait Infratech has received order from Power Grid Corporation of India. The order is for package ERS -1 for the procurement of ERS for upto 400kV transmission lines through indigenous vendor development under the company’s vertical of Emergency Restoration System Department. The order is of worth Rs 18 crore.

Maruti Suzuki India is aiming to increase its sales outlets to 3,700 by the end of FY23 amid a push to ramp up production capacity at its Manesar-based plant by 1 lakh units to cater to enhanced demand. The company has crossed the 3,500 car sales outlets mark on November 18, 2022, more than doubling it from 1,300 dealerships a decade ago. The company currently has presence in around 2,250 cities and towns in India. The company added 237 sales outlets in 2021-22 and further 170 outlets between April-October this fiscal year.

Xelpmoc Design and Tech has sold/disposed entire stake in A D Naik TechXP to their promoter by way of signing and executing Share Transfer Form (SH-4) on November 17, 2022. The company has sold 1518 equity shares of Rs 10 each and 3039 OCPS of Rs 10 each at a consideration of Rs 88,933 and Rs 1,61,067 respectively, aggregating to Rs 2.50 lakh.

United States Food and Drug Administration (USFDA) has concluded inspection at Aurobindo Pharma’s unit - IX, an intermediate facility situated at Gundlamachnoor Village, Telangana. USFDA has inspected the said facility from November 10 to November 18, 2022. At the end of the inspection, the Company has been issued a ‘Form 483’ with 10 observations.

Aurobindo Pharma Share Price

1385.65 -0.45 (-0.03%)

17-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
Sun Pharma Inds.	1675.20
Dr. Reddys Lab	1235.40
Cipla	1238.30
Zydus Lifesciences	942.55
Lupin	2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

NMDC, 3i Infotech and KDDL to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.